期刊文献+

探讨前列腺特异性抗原的临床应用

Explore the clinical application of prostate specific antigen
暂未订购
导出
摘要 目的 :探讨前列腺特异性抗原 (ProstateSPecificAntigen .psa)在临床中的应用及本地区的正常参考值。方法 :用ELISA双抗体夹心法检测 15例前列腺癌、2 5例良性前列增生患者血PSA浓度并与 6 0例健康人作比较。结果 :前列腺癌 (PorstateCancer,CaP)组病人血清PSA为 38.15± 2 9.76 (X±Sng/ml下同 ) ;良性前列腺增生 (BenignProstateHyperplasia ,BPH)组为 6 .2 8± 5 .2 0 ;健康对照组为 2 .75±1.0 2 ,三者之间均有显著性差异 (P <0 .0 1)。将PSA值与年龄作相关分析 ,得r=0 .5 2 ,P <0 .0 1。结论 :血清PSA可作为诊断和鉴别前列腺增生和良性前列腺癌增生的一个很有价值的指标 ,本地区正常男性以PSA≤ 4ng/ml为正常参考值 ,但在分析 6 0岁以上的老年人时 。 Objective: To explore the role of prostate specific antigen(PSA) in clinic and the lical normal reference value. Method: Datected the serum PSA concentration of 15 patients with prostate cancer and 25 patients with benign prostatic hyperplasia comqaring with 60 health persons by ELISA Double Antiboies Sandwith. Results: The serum PSA concentration in patient with prostate cancer was 38.15±29.76(±s,mg/ml,the below as the asme),that in patient with benign prostatic hyperplasia was 6.28±5.20,that in health person was 2.75±1.02. There were significant fifferences among the three groups(P<0.01). Correlation: analysis was performed betowwn PSA concentration and age, r=0.52,P<0.01. Conclusion: The serum PSA was a very valuable marker in diagnosing and distinguish from prostate canccer and benign prostatic hyperplasia. PSA≤4ng/ml was difined as normal reference value in health male of this area. But the normal reference value should be raisd properly with we analyse the man over sixty.
出处 《河北医学》 CAS 2002年第4期323-325,共3页 Hebei Medicine
关键词 前列腺特异性抗原 前列腺肿瘤 良性前列腺增生 Prostate-Specific Antign Prostate neoplasm Benign Prostate Hyperplasia
  • 相关文献

参考文献6

二级参考文献35

  • 1雷建平,李炎唐.前列腺特异抗原在前列腺癌诊治中的意义[J].中华泌尿外科杂志,1996,17(3):165-167. 被引量:11
  • 2刘庆鑫,李胜文,鲁学军,张志宏,孔祥林,王文波,肖连升.PSA、PSAD诊断前列腺癌的临床意义[J].中华泌尿外科杂志,1997,18(7):411-413. 被引量:14
  • 3[9] Kawakami M,et al.Enhanced expression of prostate-specific m embrane antigen gene in prostate cancer as revealed by in situ hybridization [J].Cancer Res,1997,57∶2321-2324.
  • 4[10] Carter RE,et al.Prostate-specific membrane antigen is a hydr olase with substrate and pharmacologic characteristics of a neuropeptidase[J]. Proc Natl Acad Sci USA,1996,93∶749-753.
  • 5[11] Bzdega T,et al.Molecular cloning of a peptidase against N-ac etylaspartylglutamate from a rat hippocampal cDNA library[J].J Neurochem, 1997,69∶2270-2277.
  • 6[12] Su Sl,et al.Alternatively spliced variants of prostate-speci fic membrane antigen RNA:ratio of expression as a potential measurement of progr ession[J].Cancer Res,1995,55∶1441-1443.
  • 7[13] Fair WR,et al.Prostate-specific membrane antigen[J].Prosta te,1997,32∶140-148.
  • 8[14] Israeli RS,et al.Sensitive nested reverse transcription polym erase chain reaction detection of circulating prostatic tumor cells:comparison o f prostate-specific membrane antigen and prostate-specific antigen-based assays[J].Cancer Res,1994,54∶6306-6310.
  • 9[15] Israeli RS,et al.Sensitive detection of prostatic hematogenou s tumor cell dissemination using prostate specific antigen and prostate specific membrane-derived primers in the polymerase chain reaction[J].J Urol,1995,153 ∶573~555.
  • 10[16] Grasso YZ,et al.Combined nested RT-PCR assay for prostate-s pecific antigen and prostate-specific membrane antigen in prostate cancer patie nts :correlation with pathological stage[J].Cancer Res,1998,58∶1456-1459 .

共引文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部